Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,938.00 0.00 (0.00%)

Bid:

1,802.00

Ask:

1,999.00

Spread: 197.00 (10.932%)

Market Cap: £77.72b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

London's FTSE 100 falls as healthcare, bank stocks decline

Jan 28 (Reuters) - ‍The UK's blue-chip index declined on Wednesday, weighed down by losses in banks and ⁠healthcare stocks, as investors parsed corpor...

Citi starts AstraZeneca at 'buy', takes 'neutral' stance on GSK

(Sharecast News) - Analysts at Citi initiated coverage of AstraZeneca and GSK on Tuesday, taking a bullish stance on the former but a more cautious vi...

LONDON BROKER RATINGS: BofA raises St James's Place and Quilter

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BRIEFING: Sage quarterly revenue up; Dr Martens sales decline

(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times repo...

London stocks close flat as mining shares offset industrials weakness

Jan 26 (Reuters) - London shares closed little changed on Monday as ‍gains in mining and healthcare stocks offset weakness in industrial shares, with ...

Drugmakers turn to AI to speed trials, regulatory submissions

SAN FRANCISCO, Jan 26 (Reuters) - ⁠Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecu...

GSK's RSV treatment, Arexvy, secures approval for wider use in EU

(Alliance News) - GSK PLC on Monday said the European Commission has approved an expanded indication for its respiratory syncytial virus vaccine Arexv...

LONDON BRIEFING: GSK wins EU nod for RSV shot; Spire in early talks

(Alliance News) - GSK wins EU approval to expand use of its RSV vaccine Arexvy to all adults over 18, while Grainger unveils plans for a 195-home West...